Cell Counting Kit-8 (CCK-8) – Technical Guide for High-Throughput Cell Viability and Proliferation Assays

Overview

Cell Counting Kit-8 (CCK-8) uses WST-8, a water-soluble tetrazolium salt that is reduced by cellular dehydrogenases to a soluble formazan dye measurable at ~450 nm. Signal intensity is proportional to metabolically active cell number, enabling viability, proliferation, and drug cytotoxicity readouts with simple add-mix-read workflows and minimal hands-on time. For general assay development principles in screening workflows, see the Assay Guidance Manual hosted by the NCBI Bookshelf (U.S. National Library of Medicine): Assay Guidance Manual. Additional open biomedical resources are available through PubMed and PMC: PubMed and PMC.

Assay principle and chemistry

WST-8 accepts electrons from NAD(P)H-dependent dehydrogenases via intermediate electron carriers in viable cells to produce an orange water-soluble formazan. Absorbance at 450 nm (reference 650–690 nm optional) correlates linearly with viable cell number over a broad dynamic range. For background on enzymology and biochemical assay design, consult the NIH research training portal: NIH Research & Training and the NIST measurement science resources for absorbance instrumentation and linearity verification: NIST Measurement Science.

Advantages vs. MTT/XTT/MTS and resazurin

• No cell lysis required; product is water-soluble → direct read at 450 nm.

• Higher sensitivity and lower cytotoxicity than MTT; suitable for time-course measurements.

• Compatible with phenol-red media and serum (validate lot), but see Interferences below.
  For biosafety and good laboratory practice in mammalian cell culture, refer to CDC laboratory safety guidance: CDC Laboratory Safety.

Materials and compatibility

• Adherent or suspension mammalian cells (authenticate lines; see NCI resources: NCI Research Resources).

• Clear, flat-bottom 96- or 384-well microplates; verify plate reader settings per FDA scientific instrumentation best practices: FDA Science & Research.

• CO₂ incubator, Class II biosafety cabinet. Biosafety and biosecurity policy background: NIH Guidelines for laboratory work: NIH Guidelines.

• Disposal of chemical/biological waste per EPA guidance: EPA Hazardous Waste Overview.

• Personal protective equipment (PPE) and training aligned with OSHA: OSHA Laboratory Safety.

For conceptual cell biology refreshers that aid training and onboarding, see the University of Utah’s Learn.Genetics program: Learn.Genetics (utah.edu).

Recommended plate layout

• A1–A12: Blank media + CCK-8 (no cells) = Blank

• Row B: Vehicle controls (cells + vehicle) = 0% inhibition

• Row C–H: Test article dose-response (e.g., 10-point 1:3 serial dilution, n=3–4)

• Optional: Positive-control cytotoxin (e.g., staurosporine) = 100% inhibition
  General HTS plate design and QC concepts are summarized in the Assay Guidance Manual: AGM Plate Design.

Protocol (96-well format)

1. Seed cells at empirically determined density (e.g., 3–10 × 10³ cells/well, 100 µL). Allow to attach overnight if adherent.

2. Treat with compounds (final DMSO ≤ 0.5–1% v/v). Incubate 24–72 h depending on biology.

3. Equilibrate plate to room temperature for 10 min.

4. Add CCK-8 reagent at 10 µL per 100 µL culture (final 1:10).

5. Incubate 30–180 min at 37 °C, protect from light. Time should fall within the linear signal window (pre-validated).

6. Read absorbance at 450 nm (optional reference 650–690 nm) on a calibrated microplate reader; for photometry best practices, see NIST calibration concepts: NIST Photometry.

7. Record raw A450 (and Aref if used).

Laboratory hygiene and biosafety steps should comply with institutional EHS; see Harvard EHS overview as an example of university guidance: Harvard EHS. Additional university safety frameworks: Stanford EHS Stanford EHS and UC Davis Safety Services UC Davis Safety Services.

Data reduction and calculations

1. Background subtraction:
   Anet=A450,  sample−A450,  blankA_{net} = A_{450,\;sample} – A_{450,\;blank}Anet​=A450,sample​−A450,blank​

2. Normalize to vehicle controls:
   % Viability=100×Anet,  sampleA‾net,  vehicle\%\,Viability = 100 \times \dfrac{A_{net,\;sample}}{\overline{A}_{net,\;vehicle}}%Viability=100×Anet,vehicle​Anet,sample​​

3. % Inhibition (for cytotoxicity):
   $\%Inhibition=100-\%Viability$

4. Dose–response fitting:
   Fit a 4-parameter logistic (4PL) to compute IC₅₀/EC₅₀. For statistical modeling references and reproducible research standards, see NIH Rigor & Reproducibility: NIH Rigor & Reproducibility.

5. Assay quality (Z′-factor):
   Z′=1−3(σp+σn)∣μp−μn∣Z’ = 1 – \dfrac{3(\sigma_p + \sigma_n)}{| \mu_p – \mu_n |}Z′=1−∣μp​−μn​∣3(σp​+σn​)​
   Z′ ≥ 0.5 indicates a robust screening window (see AGM: Z-factor, AGM).

For literature background and open-access methods papers, consult PMC: PMC Methods Collection.

Optimization tips

• Cell density: Keep signals in linear range; pilot titrate seeding densities.

• Incubation time with CCK-8: Shorter times reduce saturation; map time-course (e.g., 15–180 min).

• Vehicle control: Maintain constant final solvent across wells.

• Edge effects: Use plate sealers and humidified incubators; consider leaving perimeter wells for buffer.

• Reference wavelength: Using A650–690 to correct light scattering can reduce variability.

For foundational training materials in biology that can support new staff, see MIT OpenCourseWare (Biology): MIT OCW – Biology.

Known interferences and controls

• Strong antioxidants/reductants (e.g., ascorbate, dithiothreitol) can chemically reduce WST-8 → false-high signal.

• Colored compounds absorbing near 450 nm can bias readouts. Use compound-only + CCK-8 (no cells) controls to measure optical interference.

• Mitochondrial modulators shift dehydrogenase activity independent of cell number. Validate with orthogonal assays (e.g., ATP, LDH release).

• Serum lots and phenol red typically compatible but verify background and linearity.

• Long incubations may approach saturation; keep within validated kinetic window.

For general chemical safety and compatibility, consult NIH OSP and OSHA: NIH OSP and OSHA Laboratory Safety.

Multiplexing and orthogonal confirmation

• Combine CCK-8 with microscopy or cell counting post-read if non-destructive conditions are maintained.

• Pair with LDH release for membrane integrity or caspase-3/7 activity for apoptosis.

• Include colony formation or EdU incorporation for proliferation confirmation.
  Open protocols and reproducible workflows are widely discussed in PMC and the Assay Guidance Manual: PMC Protocols | AGM Workflows.

Troubleshooting quick table

• Low signal: Too few cells, short incubation, reagent expired, instrument calibration needed (NIST reference): NIST Instruments.

• High background: Reagent left too long, dirty plates, colored media components; increase references and blanks.

• Poor reproducibility: Uneven seeding, edge effects, inconsistent DMSO. Use multi-channel pipettes and plate maps.

• Non-linear dose–response: Off-target metabolism; confirm with orthogonal methods and check compound solubility.

Quality and compliance notes

• Follow institutional EHS policies (examples: Harvard EHS, Stanford EHS, UC Davis Safety).

• Biosafety risk assessment per CDC and NIH guidance: CDC Lab Safety | NIH Guidelines.

• Chemical/biological waste and sharps handling per EPA and OSHA: EPA Hazardous Waste | OSHA.

• For research transparency and access, prioritize PubMed and PMC indexing: PubMed | PMC.

Example 96-well timing matrix (for optimization)

• Seeding densities: 2.5k, 5k, 10k cells/well.

• CCK-8 incubation: 30, 60, 120 min.

• Acceptance: CV% ≤ 15 for controls, Z′ ≥ 0.5, linearity R2≥0.98R^2 \ge 0.98R2≥0.98 vs cell number.

FAQ (SEO-friendly)

Q1: What wavelength for CCK-8?
A: Read at ~450 nm with optional reference 650–690 nm. Calibration and linearity concepts: NIST Photometry.

Q2: Can I use phenol-red media?
A: Yes, typically compatible; verify background and linearity. General assay setup: Assay Guidance Manual.

Q3: Is CCK-8 cytotoxic?
A: Low cytotoxicity at recommended ratios; suitable for repeated reads within validated windows. For biosafety context: CDC Lab Safety.

Q4: How to report results reproducibly?
A: Provide plate maps, raw A450, blanks, normalization method, 4PL fit, IC₅₀ with CI, and Z′. See NIH reproducibility: NIH Rigor & Reproducibility.

Q5: Where to find peer-reviewed examples?
A: Search PubMed and filter for free full text in PMC: PubMed | PMC.

Copy-ready “How to cite your CCK-8 method” (Methods section template)

“Cell viability was quantified using the WST-8 based Cell Counting Kit-8 (CCK-8). Cells were seeded in 96-well plates (5 × 10³ cells/well) and treated as indicated. After incubation for 48 h, 10 µL of CCK-8 reagent was added to 100 µL culture medium and incubated at 37 °C for 60 min protected from light. Absorbance at 450 nm (reference 650 nm) was recorded using a calibrated microplate reader. Background-subtracted signals were normalized to vehicle-treated controls, and dose–response curves were fitted with a 4-parameter logistic model to determine IC₅₀ values. Assay quality was monitored using Z′-factor with positive and negative controls.”

Internal linking & schema tips (for SEO)

• Add internal links from category pages like Cell Viability Assays, Cytotoxicity Assays, WST-8 Kits, Microplate Readers.

• Use FAQPage and HowTo JSON-LD for this article.

• Include alt text: “CCK-8 WST-8 cell viability absorbance at 450 nm in 96-well plate.”

• Optimize H1/H2/H3 for “Cell Counting Kit-8,” “WST-8 cell viability,” “450 nm absorbance,” “IC50 calculation,” “Z-factor.”

.gov and .edu hyperlinks used above (embedded inline):

• NCBI Bookshelf – Assay Guidance Manual (.gov)

• PubMed (.gov)

• PubMed Central (PMC) (.gov)

• NIH Research & Training (.gov)

• NCI Research Resources (.gov)

• FDA Science & Research (.gov)

• CDC Laboratory Safety (.gov)

• EPA Hazardous Waste (.gov)

• NIH Guidelines (.gov)

• NIST Measurement Science (.gov)

• NIST Photometry (.gov)

• OSHA Laboratory Safety (.gov)

• NIH Rigor & Reproducibility (.gov)

• Learn.Genetics (University of Utah) (.edu)